Font Size: a A A
Keyword [Inflammatory bowel]
Result: 161 - 180 | Page: 9 of 10
161. The Research Of Over-expression Of CXCR4on Mesenchymal Stem Cells Protect Against Ulcerative Colitis And Synergistic Effect Of Compound Sophorae Decoction
162. The Molecular Mechanism Study Of Jiawei Huangqin Decoction Regulating IL-6/STAT3Signaling Pathway To Inhibit Cancerization Of Inflammatory Bowel Disease (IBD) On The Basis Of "Preventing Disease From Exacerbating" Theory
163. The Role Of Th-1and Th-17Cytokines In The Pathogenesis Of Murine Autoimmune Cholangitis And Colitis
164. Pogostone Ameliorates TNBS-induced Inflammatory Bowel Disease:An Immunomodulation Study On T Cell
165. The Role Of Stress And Coping Behavior In Inflammatory Bowel Disease
166. The Epidemiological Characteristics, Environmental Factors And Relapse Factors In Inflammatory Bowel Disease In Yunnan Province
167. Aryl Hydrocarbon Receptor Activation Involved In Ameliorating Inflammatory Bowel Disease And The Regulation Of Intestinal Epithelial Derived IL-7
168. The Effect Of Heme Oxygenase-1 On Inflammatory Boweldisease By Regulating And Suppressing Th17 Cells
169. HMGB1 Regulates Th17 Response Involved In The Pathogenesis Of Experimental Colitis In Mice And Aloe Emodin Intervention Study
170. Alterations And Clinical Efficacy Accessment Of Syndecan-1 In Inflammatory Bowel Diseases
171. Triptolide Ameliorates Intestinal Inflammation In Inflammatory Bowel Disease (Crohn’s Disease) By Mechanisms Involving Suppression Of IL-6/STAT3 Signaling Pathway
172. Characteristics Of Predominant Intestinal Microbiota And The Relationships Between The Pathogenesis And The Enterobacteria Communities In Chinese Patients With Irritable Bowel Syndrome And Inflammatory Bowel Disease
173. Preliminary Study On The Therapeutic Mechanism For Inflammatory Bowel Disease And Solid Preparation Of Allyl Methyl Disulfide
174. Citrus Nobiletin Rebanlances Intestinal Dysmotility And Suppresses Trinitrobenzene Sulfonic Acid-induced Experimental Colitis
175. Confocal Endomicroscopic In-Vivostem Cell Tracking And Mucosal Physiology-Microbiota Interaction Study
176. Distinct Dysbiosis Ocurred In Inflammatory Bowel Disease During Quiescent Stage
177. The Role Of INKT Cells, CCL25/CCR9 Interaction And Hyperhomocysteinemia In The Pathogenesis Of Inflammatory Bowel Disease
178. The Immunomodulation Effects And Mechanisms Of Cathelicidin-related Antimicrobial Peptide(CRAMP)in Mouse Models Of Intestinal Colitis And Asthma
179. Proteomic Screening Of Disease Specific And Treatment Monitoring Serum Biomarkers Of Inflammatory Bowel Disease
180. Colonic Paneth Cell Metaplasia Regulates IL23/ Th17 Axis Via TLR4 Pathway In The Pathogenesis Of Inflammatory Bowel Disease
  <<First  <Prev  Next>  Last>>  Jump to